• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 患者在行经静脉导线/器械(TLE)拔除术后行 CRT 植入:是否由综合征冠状病毒 2(SARS-COV-2)感染引发的心内膜炎?一例报告。

CRT implantation after transvenous lead/device extraction (TLE) in a patient with COVID-19: Endocarditis triggered by syndrome coronavirus 2 (SARS-COV-2) infection? A case report.

机构信息

Electrophysiology and Cardiac Pacing Unit, A.O.R.N, Ospedali dei Colli-Monaldi, Naples, Italy.

Department of Intensive Care Unit, A.O.R.N, Ospedali dei Colli-Cotugno, Naples, Italy.

出版信息

Pacing Clin Electrophysiol. 2022 Jun;45(6):807-810. doi: 10.1111/pace.14218. Epub 2022 Apr 29.

DOI:10.1111/pace.14218
PMID:33720392
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8251177/
Abstract

In the era of coronavirus disease 2019 (COVID-19), the management of cardiac implantable electronic devices infections with concomitant viral infection has not been completely defined yet. In this explorable context, we report the first experience of a Cardiac resynchronization therapy with defibrillator (CRT-D) implantation after transvenous lead extraction for endocarditis in a COVID-19 patient. We describe both the measures and procedures implemented to reduce the cross-infection in the operating room and our clinical practice to improving procedure effectiveness on patient care.

摘要

在 2019 冠状病毒病(COVID-19)时代,心脏植入式电子设备合并病毒感染的管理尚未完全确定。在这个可探索的背景下,我们报告了首例 COVID-19 患者经心内膜炎经静脉导线拔除后行心脏再同步治疗除颤器(CRT-D)植入的经验。我们描述了为降低手术室交叉感染而实施的措施和程序,以及为提高对患者护理的程序效果而采取的临床实践。

相似文献

1
CRT implantation after transvenous lead/device extraction (TLE) in a patient with COVID-19: Endocarditis triggered by syndrome coronavirus 2 (SARS-COV-2) infection? A case report.COVID-19 患者在行经静脉导线/器械(TLE)拔除术后行 CRT 植入:是否由综合征冠状病毒 2(SARS-COV-2)感染引发的心内膜炎?一例报告。
Pacing Clin Electrophysiol. 2022 Jun;45(6):807-810. doi: 10.1111/pace.14218. Epub 2022 Apr 29.
2
High recurrence of device-related adverse events following transvenous lead extraction procedure in patients with cardiac resynchronization devices.心脏再同步治疗装置患者经静脉导线拔除术后器械相关不良事件的高复发率。
Eur J Heart Fail. 2016 Oct;18(10):1270-1277. doi: 10.1002/ejhf.558. Epub 2016 May 12.
3
Safety and Effectiveness of Transvenous Lead Extraction in Patients with Infected Cardiac Resynchronization Therapy Devices; Is It More Risky than Extraction of Other Systems?经静脉心脏再同步治疗装置感染患者的安全性和有效性;与其他系统相比,其风险是否更高?
Int J Environ Res Public Health. 2022 May 10;19(10):5803. doi: 10.3390/ijerph19105803.
4
Lead extraction: The road to successful cardiac resynchronization therapy.导线拔除:通往成功心脏再同步治疗之路。
Cardiol J. 2015;22(2):188-93. doi: 10.5603/CJ.a2014.0064. Epub 2014 Oct 9.
5
Efficacy and safety of transvenous lead extraction in 108 consecutive patients: a single-centre experience.108例连续患者经静脉导线拔除术的疗效与安全性:单中心经验
Interact Cardiovasc Thorac Surg. 2019 May 1;28(5):704-708. doi: 10.1093/icvts/ivy351.
6
Same-day discharge after transvenous lead extraction: feasibility and outcomes.经静脉导线拔除术后当日出院:可行性和结果。
Europace. 2023 Feb 16;25(2):586-590. doi: 10.1093/europace/euac185.
7
Risk Factors and Long-Term Survival of Octogenarians and Nonagenarians Undergoing Transvenous Lead Extraction Procedures.八旬和九旬患者行经静脉心脏起搏器和除颤器导线拔除术的风险因素和长期生存。
Gerontology. 2021;67(1):36-48. doi: 10.1159/000511358. Epub 2020 Nov 26.
8
Complications of permanent cardiac pacing in patients with persistent left superior vena cava.永存左上腔静脉患者永久性心脏起搏的并发症
Cardiol J. 2014;21(2):128-37. doi: 10.5603/CJ.a2014.0006. Epub 2014 Feb 14.
9
Low Utilization of Lead Extraction Among Patients With Infective Endocarditis and Implanted Cardiac Electronic Devices.感染性心内膜炎合并植入式心脏电子设备患者中导线拔除术的低利用率
J Am Coll Cardiol. 2023 May 2;81(17):1714-1725. doi: 10.1016/j.jacc.2023.02.042.
10
Impact of anticoagulation therapy on outcomes in patients with cardiac implantable resynchronization devices undergoing transvenous lead extraction: A substudy of the ESC-EHRA EORP ELECTRa (European Lead Extraction ConTRolled) Registry.抗凝治疗对接受经静脉导线拔除术的心脏植入式再同步化治疗设备患者预后的影响:ESC-EHRA EORP ELECTRa(欧洲导线拔除对照)注册研究的一项子研究
J Cardiovasc Electrophysiol. 2019 Jul;30(7):1086-1095. doi: 10.1111/jce.13946. Epub 2019 Apr 29.

引用本文的文献

1
SARS-CoV-2-related cardiovascular complications in the tropics.热带地区与严重急性呼吸综合征冠状病毒2相关的心血管并发症
Trop Med Health. 2022 Dec 19;50(1):94. doi: 10.1186/s41182-022-00474-9.
2
Cardiovascular complications and predictors of mortality in hospitalized patients with COVID-19: a cross-sectional study from the Indian subcontinent.COVID-19住院患者的心血管并发症及死亡预测因素:一项来自印度次大陆的横断面研究。
Trop Med Health. 2022 Dec 19;50(1):95. doi: 10.1186/s41182-022-00481-w.
3
A clinical profile of infective endocarditis in patients with recent COVID-19: A systematic review.近期感染 COVID-19 患者感染性心内膜炎的临床特征:一项系统评价。
Am J Med Sci. 2022 Jul;364(1):16-22. doi: 10.1016/j.amjms.2022.02.005. Epub 2022 Feb 27.

本文引用的文献

1
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis.欧洲心脏病学会在 COVID-19 大流行期间心血管疾病的诊断和管理指南:第 1 部分-流行病学、病理生理学和诊断。
Eur Heart J. 2022 Mar 14;43(11):1033-1058. doi: 10.1093/eurheartj/ehab696.
2
Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association.COVID-19 大流行期间心脏电生理学的指南:心律学会 COVID-19 工作组;美国心脏病学会电生理学分会;美国心脏协会临床心脏病学理事会心电图和心律失常委员会。
Heart Rhythm. 2020 Sep;17(9):e233-e241. doi: 10.1016/j.hrthm.2020.03.028. Epub 2020 Apr 1.
3
Anesthetic Management of Patients with COVID 19 Infections during Emergency Procedures.COVID-19 感染患者在急诊手术期间的麻醉管理。
J Cardiothorac Vasc Anesth. 2020 May;34(5):1125-1131. doi: 10.1053/j.jvca.2020.02.039. Epub 2020 Feb 28.
4
European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).欧洲心脏病学会(EHRA)关于如何预防、诊断和治疗心脏植入式电子设备感染的国际共识文件——得到了心律学会(HRS)、亚太心律学会(APHRS)、拉丁美洲心律学会(LAHRS)、心血管感染性疾病国际学会(ISCVID)和欧洲临床微生物学和传染病学会(ESCMID)的认可,该共识文件是与欧洲心胸外科学会(EACTS)合作制定的。
Europace. 2020 Apr 1;22(4):515-549. doi: 10.1093/europace/euz246.
5
Incidence and Predictors of Perioperative Complications With Transvenous Lead Extractions: Real-World Experience With National Cardiovascular Data Registry.经静脉导线拔除术围手术期并发症的发生率及预测因素:国家心血管数据注册中心的真实世界经验。
Circ Arrhythm Electrophysiol. 2018 Feb;11(2):e004768. doi: 10.1161/CIRCEP.116.004768. Epub 2018 Feb 16.
6
2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.2017年心律学会心血管植入式电子装置导线管理与拔除专家共识声明
Heart Rhythm. 2017 Dec;14(12):e503-e551. doi: 10.1016/j.hrthm.2017.09.001. Epub 2017 Sep 15.
7
Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA).经静脉导线拔除:心律学会关于设施、培训、适应症及患者管理的专家共识:本文件获美国心脏协会(AHA)认可。
Heart Rhythm. 2009 Jul;6(7):1085-104. doi: 10.1016/j.hrthm.2009.05.020. Epub 2009 May 22.